Biology subjects

Albeck, S.

Publications and source records attributed to Albeck, S..

9 recordsLinked to original sources

bioRxiv2025

Structure-based design of antibody repertoires with drug-like properties

Animal immunization is the prevalent strategy for discovering antibody therapeutics1, but it is a lengthy and poorly controlled process. As an alternative, synthetic antibody repertoires deliver antibodies without animal welfare concerns, but the resulting antibodies often fail to exhibit "drug-like" biophysical properties1,2. Modern repertoires have improved developability by using a handful of frameworks with desirable biophysical properties, but at the cost of reduced structural diversity3-6. We developed a principled structure- and energy-based strategy, called CADAbRe, to navigate the complex tradeoffs between developability and structural diversity in repertoire design. The designed repertoire comprises billions of antibodies that are predicted to be stable and foldable, built from hundreds of different frameworks and hundreds of thousands of designed CDR H3s. We also developed an economical and scalable strategy for synthesizing large antibody repertoires, and as a proof of concept, designed and synthesized a 500-million variant phage display repertoire. Selections against four unrelated targets produced structurally diverse binders that exhibited drug-like properties, two of which were readily formatted as bispecifics for functional studies. Furthermore, one of the binders targets a challenging, highly charged surface. The proof-of-concept repertoire is available for academic research. We envision that the CADAbRe approach and repertoire will accelerate and rationalize antibody discovery while addressing animal-welfare concerns7.

synthetic biology↗

bioRxiv2025

A multiplexed approach for genetic screening of human cells by electron microscopy uncovers a critical effector of mitochondrial cristae shape

Mitochondria form complex and diverse membrane-architectures essential for their multiple functions. Whereas critical proteins sculpting mitochondrial membranes have been identified, the molecular basis for many key features remains enigmatic. Exploration of membrane ultrastructure, in general, is limited by the tradeoff between resolution and throughput: electron microscopy (EM) is essential to resolve their ultrastructure but lacks scalability for systematic functional discovery. To overcome this limitation, we developed a high-resolution screening pipeline for EM of multiplexed human cell pools, hMultiCLEM (human Multiplexed Correlative Light and EM). To showcase the power of hMultiCLEM we performed a genetic screen exploring mitochondrial ultrastructure. hMultiCLEM confirmed proposed cristae modulators and uncovered additional ones illuminating the protein networks driving cristae organization. Validation of candidates highlighted an intermembrane space (IMS) protein linked to Menieres disease, which we named MISHA (Mitochondrial-IMS membrane-SHApe-impacting protein). More broadly, hMultiCLEM transforms the EM field, enabling genetic/chemical screening in basic and medical research.

cell biology↗

bioRxiv2025

A pharmacological modality to sequester homomeric proteins

Molecules that can perturb protein-protein interactions have an immense impact on chemical biology and therapeutics. However, such compounds typically rely on accessory proteins to function, such as E3 ligases in the case of targeted degradation, which may restrict their target and tissue scope or lead to resistance. Here we alleviate the need for accessory proteins with a novel pharmacological modality to knock-down protein function. Our strategy exploits protein symmetry as a selective vulnerability, and is widely applicable owing to the ubiquitous nature of homomeric proteins in cellular systems. We target homomeric proteins with PINCHs (Polymerization Inducing Chimeras) - bifunctional molecules composed of two linked ligands that act as bridges between homomers and trigger their supramolecular assembly into insoluble polymers. We design PINCHs that achieve efficient polymerization of three homomeric targets. In cells, we observed that a PINCH targeting Keap1 exhibited a longer duration of action compared to its monomeric inhibitor, and a PINCH targeting BCL6 displayed selective and improved B cell toxicity compared to its monomeric parent. Our results highlight PINCHs as a novel and general strategy to modulate and knock out protein function.

biochemistry↗

bioRxiv2025

Differential effects of immobilized CCL21 and ICAM1 on TILs with distinct expansion properties

Adoptive T cell therapy (ACT), particularly tumor-infiltrating lymphocyte (TIL), holds great promise for cancer treatment, yet it still faces major challenges such as variability in expansion rates, cytotoxic potency and immune suppression. Recent studies suggest that a "synthetic immune niche" (SIN), composed of immobilized CCL21 and ICAM-1, enhances both the expansion and cytotoxicity of murine and patient-derived T cells. Here, we investigate the mechanism underlying the expansion variability by identifying morphological and molecular markers that distinguish low- and high-expanding TILs and predict their ex vivo expansion potential. We further developed novel SIN-based strategies that differentially reinforce the efficacy of both low- and high-expanding TILs. We demonstrate that a 14-day REP with feeder cells and SIN facilitates the proliferation of the low-expanding cells, while the high-expanding counterparts benefit from a sequential expansion protocol of 7 days with feeder cells only, followed by 7 days with SIN treatment. At the end of the REP both TIL populations display high levels of granzyme B and perforin and reduced levels of exhaustion markers. In conclusion, our findings demonstrate that the refined CCL21+ICAM1 SIN treatment improves expansion rates and activation profiles of both TIL populations, thereby enabling personalized SIN-enhanced protocols for TIL-based immunotherapy.

bioengineering↗

bioRxiv2024

An unconventional interaction interface between the peroxisomal targeting factor Pex5 and Eci1 enables PTS1 independent import

Accurate and regulated protein targeting to organelles is crucial for eukaryotic cellular function and homeostasis. This has driven the evolution of targeting signals on proteins and the targeting factors that recognize them. One example for this is peroxisomal matrix proteins, the majority of which rely on the targeting factor Pex5 to correctly localize and function. While most Pex5 cargos contain a Peroxisomal Targeting Signal type 1 (PTS1), in recent years it has become clear that more binding interfaces exist, and that targeting by Pex5 is more complex than previously thought. Here, we uncover that the matrix protein Eci1 can reach peroxisomes in the absence of its PTS1. By solving the structure of a complex between full length yeast Pex5 and Eci1 using Cryo-Electron Microscopy, we could identify their binding interfaces. This allowed us to map an additional binding interface that is independent of the canonical PTS1-mediated binding site. Our work brings forward a solution to a long-standing mystery regarding Eci1 targeting to peroxisomes. More globally, it demonstrates the intricate and complex nature of organelle targeting and how it has evolved to serve the complex eukaryotic environment.

cell biology↗

bioRxiv2023

The impact of molecular variants, crystallization conditions and space group on structure-ligand complexes: A case study on Bacterial Phosphotriesterase Variants and complexes

While attempting to study the 3D structure of proteins with bound ligands, one often encounters considerable difficulties. We illustrate, as an example, the bacterial enzyme phosphotriesterase and specifically examine the effects of multiple factors such as the molecular constructs, ligands used during protein expression and purification, crystallization precipitance, and space group on the visualization of molecular complexes of organophosphate ligands bound to the enzyme. We analyzed twelve crystal structures of the different phosphotriesterase constructs derived by directed evolution in both apo and holo forms (in complex with organophosphate analogs), with resolutions up to 1.38 [A]. Crystals obtained from three different crystallization conditions, crystallized in four space groups, with and without N-terminal tags, were utilized to investigate the impact of these factors on visualizing molecular complexes of ligands bound to the enzyme. The study revealed that residual tags used for protein expression can lodge in the active site and hinder ligand binding. Additionally, the space groups in which the proteins are crystallized can significantly impact the visualization of the organophosphate ligands bound to the phosphotriesterase. The study also reveals that the crystallization precipitants can compete with and even preclude ligand binding, leading to false positives or the incorrect identification of lead drug candidates, which is particularly crucial for ligands with pharmacological and toxicological contexts. Overall, this study provides valuable insights into the challenges and considerations involved in studying the 3D structure of proteins with bound ligands, highlighting the importance of careful experimental design and rigorous data analysis to ensure the accuracy and reliability of the resulting protein-ligand structures.

biochemistry↗

bioRxiv2022

How talin allosterically activates vinculin

The talin-vinculin axis is a key mechanosensing component of cellular focal adhesions. How talin and vinculin respond to forces and regulate one another remains unclear. By combining single molecule magnetic tweezer experiments, Molecular Dynamics simulations, actin bundling assays, and adhesion assembly experiments in live cells, we here discover a two-ways allosteric network within vinculin as a regulator of the talin-vinculin interaction. We directly observe a maturation process of vinculin upon talin binding which reinforces the binding to talin at a rate of 0.03 s-1. This allosteric transition can compete with force-induced dissociation of vinculin from talin only at 7-10 pN. Mimicking the allosteric activation by mutation yields a vinculin molecule that bundles actin and localizes to focal adhesions in a force-independent manner. Hence, the allosteric switch confines talin-vinculin interactions and focal adhesion build-up to intermediate force levels. The allosteric vinculin mutant is a valuable molecular tool to further dissect the mechanical and biochemical signalling circuits at focal adhesions and elsewhere.

biophysics↗

bioRxiv2020

Bringing BOS to light: Uncovering the key enzyme in the biosynthesis of the neurotoxin β-ODAP in Grass Pea (Lathyrus sativus L.)

Grass pea (Lathyrus sativus L.) is a grain legume commonly grown in parts of Asia and Africa for food and forage. While being a highly nutritious and robust crop, able to survive both drought and floods, it produces a neurotoxic compound, {beta}-N-oxalyl-L-,{beta}-diaminopropionic acid ({beta}-ODAP), which can cause a severe neurological disorder if consumed as a main diet component. So far, the enzyme that catalyzes the formation of {beta}-ODAP has not been identified. By combining protein purification and enzymatic assays with transcriptomic and proteomic analyses, we were able to identify the enzyme {beta}-ODAP synthetase (BOS) from grass pea. We show that BOS is an HXXXD-type acyltransferase of the BAHD superfamily and that its crystal structure is highly similar to that of plant hydroxycinnamoyl transferases. The identification of BOS, more than 50 years after it was proposed, paves the way towards the generation of non-toxic grass pea cultivars safe for human and animal consumption.

plant biology↗

bioRxiv2018

Expression of a recombinant, 4’-Phosphopantetheinylated, active M. tuberculosis Fatty acid Synthase I in E. coli

Fatty acid synthase 1 (FAS I) from Mycobacterium. tuberculosis (Mtb) is an essential protein and a promising drug target. FAS I is a multi-functional, multi-domain protein that is organized as a large (1.9 MDa) homohexameric complex. Acyl intermediates produced during fatty acid elongation are attached covalently to an acyl carrier protein (ACP) domain. This domain is activated by the transfer of a 4-Phosphopantetheine (4-PP, also termed P-pant) group from CoA to ACP catalyzed by a 4-PP transferase, termed acyl carrier protein synthase (AcpS). In order to obtain an activated FAS I in E. coli, we transformed E. coli with tagged Mtb fas1 and acpS genes encoded by a separate plasmid.\n\nWe induced the expression of Mtb FAS I following induction of AcpS expression. FAS I was purified by Strep-Tactin affinity chromatography. Activation of Mtb FAS I was confirmed by the identification of a bound P-pant group on serine at position 1808 by mass spectrometry. The purified FAS I displayed biochemical activity shown by spectrophotometric analysis of NADPH oxidation and by CoA production, using the Ellman reaction. The purified Mtb FAS I forms a hexameric complex shown by negative staining and cryo-EM. Purified hexameric and active Mtb FAS I is required for binding and drug inhibition studies and for structurefunction analysis of this enzyme. This relatively simple and short procedure for Mtb FAS I production should facilitate studies of this enzyme.

microbiology↗